Day: September 25, 2025

MUNCIE, Ind. and JEFFERSONVILLE, Ind., Sept. 25, 2025 (GLOBE NEWSWIRE) — First Merchants Corporation (Nasdaq: FRME) (“First Merchants”) and First Savings Financial Group, Inc., (Nasdaq: FSFG) (“First Savings”) today announced they have entered into a definitive merger agreement pursuant to which First Savings will merge with and into First Merchants in an all-stock transaction currently valued at approximately $241.3 million. Immediately following the merger, First Savings Bank will merge with and into First Merchants Bank. Headquartered in Jeffersonville, Indiana, First Savings operates 16 banking center locations in southern Indiana. First Savings has total assets of $2.4 billion, total loans of $1.9 billion, and total deposits of $1.7 billion earning a 1.02% return on average assets (annualized) and a 13.7% return on average...

We expect to release the Q3 2025 interim results of DSV A/S in the morning of 23 October 2025. A webcast and conference call will be held at 11:00 am CEST. At the conference call, Jens H. Lund, Group CEO, and Michael Ebbe, Group CFO, will present the Q3 2025 Interim Financial Report. The presentation will be followed by a Q&A session. Date:                 23 October 2025Time:                11:00 am CEST To attend the webcast presentation, please go to Webcast presentation – DSV Interim Financial Report Q3 2025 or go to https://investor.dsv.com/. If you wish to ask questions during the conference call, please register through this link: Conference call Q&A – DSV Interim Financial Report Q3 2025. You will receive an email with dial-in telephone numbers. We recommend participants to dial in 10 minutes prior to the...

CEDARHURST, N.Y., Sept. 25, 2025 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,200 properties leased primarily to the United States Postal Service (the “USPS”), ranging from last-mile post offices to industrial facilities, today announced the appointment of Steve Bakke as Executive Vice President, Chief Financial Officer and the Company’s Principal Financial Officer effective on or about November 5, 2025. He will be based at the Company’s headquarters in Cedarhurst, NY. “We are pleased to welcome Steve to Postal Realty,” stated Andrew Spodek, Chief Executive Officer. “Steve’s track record of success in Capital Markets, Financial and Corporate Strategy, and Investor Relations will complement us well. Additionally, his...

HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) — CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with UnitedHealthcare Insurance Company (NYSE: UNH), effective September 15, 2025, covering over 51 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid Tumor Cell Enumeration laboratory developed test (LDT). The CNSide® CSF Assay Platform supports rapid diagnoses, treatment monitoring, and treatment guidance for patients with leptomeningeal metastases. The superior clinical utility of CNSide® over standard of care has been shown in 9 peer-reviewed publications, the FORESEE clinical trial, and has been validated in the market through real-world use. More than 11,000 CNSide® tests...

MALVERN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced the appointment of Mark Guerin, CPA, CMA, CFM, as Chief Financial Officer (CFO) to help lead the Company through a pivotal phase as buntanetap continues to show promise in late-stage clinical development. Mr. Guerin has extensive experience and a successful track record in managing financial operations within biopharma companies. In 2013, he joined Onconova Therapeutics, now known as Traws Pharma, Inc. (Nasdaq: TRAW), to augment the company’s financial reporting, forecasting, and internal controls following its...

CALGARY, Alberta, Sept. 25, 2025 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor”, the “Company”), listed on the TSX Venture Exchange under the ticker QST, has secured a $9 million contract to supply clean combustion solutions to a large energy services provider in Mexico for rental over three years1. This initiative aims to significantly reduce flaring and methane emissions. Questor is proud to support the efforts in Mexico to achieve zero routine flaring by 2030 and reduce methane emissions by 30% between 2020 and 2030, consistent with the Global Methane Pledge. Questor is proud to partner with its partners in Mexico to responsibly and sustainably produce energy. This rental agreement underscores Questor’s reputation for delivering cost-effective, high-performance technology and highlights its expanding presence in global...

Vancouver, Canada, Sept. 25, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the successful convening of its inaugural Annual Scientific Advisory Board (SAB) meeting. This meeting brought together eight world-renowned professors and experts in psychiatry, addiction research, and metabolic disorders to provide strategic guidance on Clearmind’s innovative clinical and preclinical programs. A central focus of the SAB discussions was Clearmind’s lead candidate, 5-Methoxy-2-aminoindane (MEAI), currently in Phase 1/2a clinical trials for Alcohol Use Disorder (AUD). Discussions underscored MEAI’s...

ToNasdaq Copenhagen A/S   Executive ManagementBernstorffsgade 401577 København Vwww.rd.dk Telephone +45 7012 5300 25 September 2025Company announcement number 77/2025 Fixing of coupon rate effective from 1 October 2025 With effect from 1 October 2025, the coupon rate of the following bonds financing RD Euribor3®, RD Stibor3®, RD Stibor3® Green, RD Nibor3®, RD Cibor6® (RO), FlexGaranti® and RenteDyk® will be adjusted.          Please find the data in the attached file. The Executive Management Any additional questions should be addressed to Chief Analyst Hella Gebhardt Rønnebæk, Phone +45 45 13 20 68.AttachmentsNr. 77_Fastsaettelse af kuponrente pr. 01.10.2025_ukBilag til selskabsmeddelelse nr. 77-2025_uk